01:46 PM EST, 02/10/2025 (MT Newswires) -- Pliant Therapeutics ( PLRX ) sank after midday Monday after the company's shares were the subject of several rating downgrades following a Pliant announcement late Friday that it suspended enrollment and dosing in a phase 2b trial of bexotegrast for idiopathic pulmonary fibrosis.

Shares slumped nearly 59% following a surge in intraday trading volume to over 14.1 million from a daily average of about 630,000.

B. Riley adjusted its price target for Semtech's ( SMTC ) shares to $68 from $85 while keeping the buy rating.

Shares of Semtech ( SMTC ) dropped 30% as intraday trading volume rose to over 13.7 million from the stock's daily average of about 2.1 million.

Hain Celestial Group ( HAIN ) said Monday it is exploring strategic options for its personal care business as it shifts focus to its better-for-you food and beverages portfolio.

Shares retreated 14% as intraday trading volume surged to more than 2.8 million from a daily average of roughly 1.5 million.

Price: 3.20, Change: -4.59, Percent Change: -58.92